Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 24

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Vitamin D status after colorectal cancer diagnosis and patient survival according to immune response to tumour

Hamada, Tsuyoshi, Liu, Li, Nowak, Jonathan A., Mima, Kosuke, Cao, Yin, Ng, Kimmie, Twombly, Tyler S., Song, Mingyang, Jung, Seungyoun, Dou, Ruoxu, Masugi, Yohei, Kosumi, Keisuke, Shi, Yan, da Silva, Annacarolina, Gu, Mancang, Li, Wanwan, Keum, NaNa, Wu, Kana, Nosho, Katsuhiko, Inamura, Kentaro, Meyerhardt, Jeffrey A., Nevo, Daniel, Wang, Molin, Giannakis, Marios, Chan, Andrew T., Giovannucci, Edward L., Fuchs, Charles S., Nishihara, Reiko, Zhang, Xuehong, Ogino, Shuji·2018·European Journal of Cancer
DOI 10.1016/j.ejca.2018.07.130
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ejca.2018.07.130

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 37

  1. Pages, 2018, International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study, Lancet, 391, 2128, 10.1016/S0140-6736(18)30789-X · DOI · Paper page
  2. Grizzi, 2018, Evolving notions on immune response in colorectal cancer and their implications for biomarker development, Inflamm Res, 67, 375, 10.1007/s00011-017-1128-1 · DOI
  3. Berntsson, 2017, The clinical impact of tumour-infiltrating lymphocytes in colorectal cancer differs by anatomical subsite: a cohort study, Int J Canc, 141, 1654, 10.1002/ijc.30869 · DOI
  4. Fridman, 2017, The immune contexture in cancer prognosis and treatment, Nat Rev Clin Oncol, 14, 717, 10.1038/nrclinonc.2017.101 · DOI · Paper page
  5. Rozek, 2016, Tumor-infiltrating lymphocytes, Crohn's-like lymphoid reaction, and survival from colorectal cancer, J Natl Canc Inst, 108, 10.1093/jnci/djw027 · DOI
  6. Bever, 2017, An expanding role for immunotherapy in colorectal cancer, J Natl Compr Canc Netw, 15, 401, 10.6004/jnccn.2017.0037 · DOI
  7. Le, 2017, Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade, Science, 357, 409, 10.1126/science.aan6733 · DOI · Paper page
  8. Basile, 2017, Immunotherapy for colorectal cancer: where are we heading?, Expet Opin Biol Ther, 17, 709, 10.1080/14712598.2017.1315405 · DOI
  9. Ogino, 2011, Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field, Gut, 60, 397, 10.1136/gut.2010.217182 · DOI · Paper page
  10. Rajpoot, 2018, Understanding the microbiome: emerging biomarkers for exploiting the microbiota for personalized medicine against cancer, Semin Canc Biol, 10.1016/j.semcancer.2018.02.003 · DOI
  11. Morgillo, 2018, Carcinogenesis as a result of multiple inflammatory and oxidative hits: a comprehensive review from tumor microenvironment to gut microbiota, Neoplasia, 20, 721, 10.1016/j.neo.2018.05.002 · DOI
  12. Ogino, 2018, Immunoscore for (colorectal) cancer precision medicine, Lancet, 391, 2084, 10.1016/S0140-6736(18)30953-X · DOI
  13. Ng, 2008, Circulating 25-hydroxyvitamin d levels and survival in patients with colorectal cancer, J Clin Oncol, 26, 2984, 10.1200/JCO.2007.15.1027 · DOI · Paper page
  14. Zgaga, 2014, Plasma vitamin D concentration influences survival outcome after a diagnosis of colorectal cancer, J Clin Oncol, 32, 2430, 10.1200/JCO.2013.54.5947 · DOI
  15. Maalmi, 2014, Serum 25-hydroxyvitamin D levels and survival in colorectal and breast cancer patients: systematic review and meta-analysis of prospective cohort studies, Eur J Canc, 50, 1510, 10.1016/j.ejca.2014.02.006 · DOI
  16. Song, 2016, Plasma 25-hydroxyvitamin D and colorectal cancer risk according to tumour immunity status, Gut, 65, 296, 10.1136/gutjnl-2014-308852 · DOI
  17. Dou, 2016, Vitamin D and colorectal cancer: molecular, epidemiological and clinical evidence, Br J Nutr, 115, 1643, 10.1017/S0007114516000696 · DOI
  18. Sehdev, 2015, The role of aspirin, vitamin D, exercise, diet, statins, and metformin in the prevention and treatment of colorectal cancer, Curr Treat Options Oncol, 16, 43, 10.1007/s11864-015-0359-z · DOI
  19. Feldman, 2014, The role of vitamin D in reducing cancer risk and progression, Nat Rev Canc, 14, 342, 10.1038/nrc3691 · DOI · Paper page
  20. Veldhoen, 2012, Dietary influences on intestinal immunity, Nat Rev Immunol, 12, 696, 10.1038/nri3299 · DOI
  21. von Essen, 2010, Vitamin D controls T cell antigen receptor signaling and activation of human T cells, Nat Immunol, 11, 344, 10.1038/ni.1851 · DOI · Paper page
  22. Konijeti, 2016, Vitamin D supplementation modulates T cell-mediated immunity in humans: results from a randomized control trial, J Clin Endocrinol Metab, 101, 533, 10.1210/jc.2015-3599 · DOI
  23. Sarkar, 2016, Role of vitamin D in cytotoxic T lymphocyte immunity to pathogens and cancer, Crit Rev Clin Lab Sci, 53, 132, 10.3109/10408363.2015.1094443 · DOI
  24. Giovannucci, 2006, Prospective study of predictors of vitamin D status and cancer incidence and mortality in men, J Natl Canc Inst, 98, 451, 10.1093/jnci/djj101 · DOI · Paper page
  25. Ng, 2009, Prospective study of predictors of vitamin D status and survival in patients with colorectal cancer, Br J Canc, 101, 916, 10.1038/sj.bjc.6605262 · DOI
  26. Yamauchi, 2012, Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum, Gut, 61, 847, 10.1136/gutjnl-2011-300865 · DOI · Paper page
  27. Ogino, 2009, Lymphocytic reaction to colorectal cancer is associated with longer survival, independent of lymph node count, microsatellite instability, and CpG island methylator phenotype, Clin Canc Res, 15, 6412, 10.1158/1078-0432.CCR-09-1438 · DOI · Paper page
  28. Nosho, 2010, Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review, J Pathol, 222, 350, 10.1002/path.2774 · DOI · Paper page
  29. Chan, 2007, Aspirin and the risk of colorectal cancer in relation to the expression of COX-2, N Engl J Med, 356, 2131, 10.1056/NEJMoa067208 · DOI · Paper page
  30. Nosho, 2008, Comprehensive biostatistical analysis of CpG island methylator phenotype in colorectal cancer using a large population-based sample, PLoS One, 3, 10.1371/journal.pone.0003698 · DOI · Paper page
  31. Liu, 2018, Utility of inverse probability weighting in molecular pathological epidemiology, Eur J Epidemiol, 33, 381, 10.1007/s10654-017-0346-8 · DOI
  32. Hamada, 2017, Aspirin use and colorectal cancer survival according to tumor CD274 (programmed cell death 1 ligand 1) expression status, J Clin Oncol, 35, 1836, 10.1200/JCO.2016.70.7547 · DOI
  33. Janakiram, 2016, Prevention and treatment of cancers by immune modulating nutrients, Mol Nutr Food Res, 60, 1275, 10.1002/mnfr.201500884 · DOI
  34. van Harten-Gerritsen, 2015, Vitamin D, inflammation, and colorectal cancer progression: a review of mechanistic studies and future directions for epidemiological studies, Canc Epidemiol Biomarkers Prev, 24, 1820, 10.1158/1055-9965.EPI-15-0601 · DOI
  35. Meeker, 2014, Increased dietary vitamin D suppresses MAPK signaling, colitis, and colon cancer, Canc Res, 74, 4398, 10.1158/0008-5472.CAN-13-2820 · DOI
  36. Ogino, 2018, Integrative analysis of exogenous, endogenous, tumour and immune factors for precision medicine, Gut, 67, 1168, 10.1136/gutjnl-2017-315537 · DOI
  37. Ogino, 2017, Integration of pharmacology, molecular pathology, and population data science to support precision gastrointestinal oncology, NPJ Precis Oncol, 1, 40, 10.1038/s41698-017-0042-x · DOI

Cited by

Metadata

Authors
Hamada, T., Liu, L., Nowak, J. A., Mima, K., Cao, Y., Ng, K., Twombly, T. S., Song, M., Jung, S., Dou, R., Masugi, Y., Kosumi, K., Shi, Y., da Silva, A., Gu, M., Li, W., Keum, N., Wu, K., Nosho, K., Inamura, K., Meyerhardt, J. A., Nevo, D., Wang, M., Giannakis, M., Chan, A. T., Giovannucci, E. L., Fuchs, C. S., Nishihara, R., Zhang, X., & Ogino, S.
ORCID
Venue
European Journal of Cancer
Publisher
Elsevier BV
Published
2018-11
Volume
103
Pages
98-107
ISSN
0959-8049
DOI
10.1016/j.ejca.2018.07.130
Cited by
24
References
3
Language
en
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Funders
  • U.S. National Institutes of Health (P01 CA87969, UM1 CA186107, P01 CA55075, UM1 CA167552, U01 CA167552, P50 CA127003, R01 CA118553, R01 CA169141, R01 CA137178, K24 DK098311, R35 CA197735, R01 CA151993, R01 CA205406, K07 CA190673, K07 CA188126)
  • Project P Fund
  • Dana-Farber Cancer Institute
  • Bennett Family Fund
  • Entertainment Industry Foundation
  • Stand Up to Cancer (SU2C) Colorectal Cancer Dream Team Translational Research (SU2C-AACR-DT22-17)
  • Uehara Memorial Foundation
  • Mochida Memorial Foundation for Medical and Pharmaceutical Research
  • Chinese Scholarship Council
  • Huazhong University of Science and Technology
  • Japan Society for the Promotion of Science
  • Overseas Research Fellowship (JP2017-775)
  • National Natural Science Foundation of China (31601077)
  • National Research Foundation of Korea (NRF-2018R1C1B6008822, NRF-2018R1A4A1022589)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.